chr10-66280489-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_013266.4(CTNNA3):c.1865G>A(p.Cys622Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000181 in 1,604,858 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. C622C) has been classified as Benign.
Frequency
Consequence
NM_013266.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151976Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000371 AC: 9AN: 242562Hom.: 0 AF XY: 0.00000761 AC XY: 1AN XY: 131330
GnomAD4 exome AF: 0.0000186 AC: 27AN: 1452882Hom.: 0 Cov.: 30 AF XY: 0.00000553 AC XY: 4AN XY: 722800
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74224
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1865G>A (p.C622Y) alteration is located in exon 13 (coding exon 12) of the CTNNA3 gene. This alteration results from a G to A substitution at nucleotide position 1865, causing the cysteine (C) at amino acid position 622 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Arrhythmogenic right ventricular dysplasia 13 Uncertain:1
This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 622 of the CTNNA3 protein (p.Cys622Tyr). This variant is present in population databases (rs367616357, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with CTNNA3-related conditions. ClinVar contains an entry for this variant (Variation ID: 240865). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CTNNA3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at